top of page
Home
About Us
Team
Science
Pipelines
Ulcerative Colitis
Atopic Dermatitis
COVID-19
Diabetes
Nonalcoholic fatty liver disease
Gout
Investor Relations
Contact
More
Use tab to navigate through the menu items.
Investor Relations
SEC Filings
Investor Relations
NEWS / EVENTS
Press Release
Events & Presentations
SEC FILINGS
STOCK INFO
GOVERNANCE
Governance Documents
3/30/26
10-K
Annual report [Section 13 and 15(d), not S-K Item 405]
html
3/6/26
8-K
Current report
html
1/5/26
8-K
Current report
html
11/17/25
NT 10-Q
Notification of inability to timely file Form 10-Q or 10-QSB
html
11/17/25
10-Q
Quarterly report [Sections 13 or 15(d)]
html
11/6/25
8-K
Current report
html
9/29/25
8-K
Current report
html
9/12/25
8-K
Current report
html
9/9/25
10-Q
Quarterly report [Sections 13 or 15(d)]
html
9/2/25
3
Initial statement of beneficial ownership of securities
html
1
2
3
4
5
1
...
1
2
3
4
5
6
7
...
7
bottom of page